Follow-up of patients with R/R FLT3-mutation–positive AML treated with gilteritinib in the phase 3 ADMIRAL trial
暂无分享,去创建一个
R. Larson | G. Martinelli | M. Levis | Sung-Soo Yoon | C. Récher | G. Schiller | A. Neubauer | N. Hosono | S. Chiba | E. Wang | A. Perl | R. Tiu | S. Strickland | Hee‐Je Kim | P. Montesinos | N. Podoltsev | E. Atallah | M. Onozawa | N. Hasabou | J. Sierra | Qiaoyang Lu | S. Yoon